Literature DB >> 1846310

Interleukin 4 receptor expression on human lung tumors and normal lung.

M F Tungekar1, H Turley, M S Dunnill, K C Gatter, M A Ritter, A L Harris.   

Abstract

Interleukin 4 (IL-4) receptors were detected by a monoclonal antibody on tumor cells of 10 of 29 squamous cell carcinomas and 6 of 17 adenocarcinomas of the lung. None of the small cell carcinomas or carcinoid tumors stained. Parallel sections stained for epidermal growth factor receptors showed that all but 2 of the IL-4 receptor-positive tumors also expressed epidermal growth factor receptors. Positive labeling for IL-4 receptors was also obtained on nonneoplastic bronchial epithelium and on lymphocytes and macrophages infiltrating the tumor stroma. The role of IL-4 and its receptor in normal human lung is unknown, but the expression of IL-4 receptors on particular subtypes of lung tumors suggests that they may have a role in differentiation or proliferation of squamous and adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846310

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.

Authors:  D J Conrad; H Kuhn; M Mulkins; E Highland; E Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Authors:  N I Obiri; J P Siegel; F Varricchio; R K Puri
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

3.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

Authors:  Jennifer L Gooch; Barbara Christy; Douglas Yee
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

4.  Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Authors:  A R Hanauske; D Degen; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

5.  Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.

Authors:  G G Hillman; R K Puri; M A Kukuruga; J E Pontes; G P Haas
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

6.  Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.

Authors:  L Kaklamanis; M I Koukourakis; R Leek; A Giatromanolaki; M Ritter; R Whitehouse; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.

Authors:  L Kaklamanis; K C Gatter; N Mortensen; A L Harris
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

8.  Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast.

Authors:  A A al-Tubuly; Y A Luqmani; S Shousha; D Melcher; M A Ritter
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

9.  Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).

Authors:  M F Tungekar; K C Gatter; M A Ritter
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.